Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 10/20 | 0.42 |
| ▸ | PPARA | Q07869 | 2/20 | 0.42 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.38 |
| ▸ | ACACB | O00763 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | RXRG | P48443 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25015612 | 0.90 | MAPT (0.40) | PPARAMRGPRX4ACACBALDH1A1MAPT | |
| SCHEMBL24802624 | 0.88 | LMNA (0.35) | PPARDPPARAMRGPRX4FFAR4ACACB | |
| SCHEMBL25015137 | 0.87 | THRB (0.43) | PPARDPPARAACACBTHRBALDH1A1 | |
| SCHEMBL22862351 | 0.87 | FFAR4 (0.43) | MRGPRX4FFAR4ACACBTHRBFFAR1 | |
| SCHEMBL24802623 | 0.87 | FFAR4 (0.43) | MRGPRX4FFAR4ACACBTHRBFFAR1 | |
| SCHEMBL24803616 | 0.87 | MAPT (0.37) | FFAR4ACACBALDH1A1MAPTHPGD | |
| SCHEMBL25014949 | 0.87 | MAPT (0.37) | FFAR4ACACBALDH1A1MAPTHPGD | |
| SCHEMBL25015619 | 0.86 | XDH (0.37) | MRGPRX4FFAR4FFAR1 | |
| SCHEMBL25015617 | 0.84 | ACACB (0.36) | PPARDPPARAMRGPRX4FFAR4ACACB | |
| SCHEMBL24806608 | 0.84 | THRB (0.37) | PPARDPPARAACACBTHRBFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230229038-A1 | LIQUID CRYSTAL DIFFRACTION ELEMENT, OPTICAL ELEMENT, IMAGE DISPLAY UNIT, HEAD-MOUNTED DISPLAY, BEAM STEERING, AND SENSOR | FUJIFILM CORPORATION (JP) | 2023-07-20 | — | — | US | disclosed |
| US-20230204968-A1 | IMAGE DISPLAY UNIT AND HEAD-MOUNTED DISPLAY | FUJIFILM CORPORATION (JP) | 2023-06-29 | — | — | US | disclosed |
| US-20230205044-A1 | LIQUID CRYSTAL DIFFRACTION ELEMENT, OPTICAL ELEMENT, IMAGE DISPLAY UNIT, HEAD-MOUNTED DISPLAY, BEAM STEERING, AND SENSOR | FUJIFILM CORPORATION (JP) | 2023-06-29 | — | — | US | disclosed |
| US-20230042009-A1 | COMPOUND, COMPOSITION, CURED SUBSTANCE, OPTICALLY ANISOTROPIC BODY, OPTICAL ELEMENT, AND LIGHT GUIDE ELEMENT | FUJIFILM CORPORATION (JP) | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230042009-A1 | COMPOUND, COMPOSITION, CURED SUBSTANCE, OPTICALLY ANISOTROPIC BODY, OPTICAL ELEMENT, AND LIGHT GUIDE ELEMENT | SP1, C5, ZYX | PPARD 4531/4885PPARA 3308/4885MRGPRX4 1017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.